Smith & Nephew buys Exogen for $68 million
This article was originally published in Clinica
Executive Summary
Smith & Nephew will buy US sonic fracture healing device company Exogen for $68 million. S&N already had a small stake in the company, which it acquired last year as part of a worldwide exclusive distribution deal.